West Pharmaceutical(WST) - 2023 Q2 - Earnings Call Presentation

Second-Quarter 2023 WST Q2 2023 Earnings 1 | --- | --- | |-------------------------------------------------------------------------------|-------| | Second Quarter Overall Net Sales $753.8M | 2.3% | | | | | | Diluted Earnings Per Share: $2.06 Adjusted Diluted Earnings Per Share: $2.11 | | "We had a solid first-half of 2023, and with the momentum of our high-value product capacity expansion projects, we are well positioned for an even better second-half of the year. While COVID-19 related sales continued to ...